3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
26
Breast Neoplasms
23
Glioma
14
Neoplasm Metastasis
13
Carcinoma, Non-Small-Cell Lung
13
Lymphoma
12
Glioblastoma
11
Neuroblastoma
10
Lung Neoplasms
10
Lymphoma, Non-Hodgkin
9
Brain Neoplasms
9
Medulloblastoma
8
Carcinoma, Renal Cell
8
Neoplasms
7
Multiple Myeloma
7
Ependymoma
7
Wilms Tumor
6
Thyroid Neoplasms
6
Sarcoma
6
Rectal Neoplasms
6
Pancreatic Neoplasms
6
Ovarian Neoplasms
6
Osteosarcoma
6
Fallopian Tube Neoplasms
6
Central Nervous System Neoplasms
6
Carcinoma, Hepatocellular
6
Uterine Cervical Neoplasms
5
Urinary Bladder Neoplasms
5
Thyroid Cancer, Papillary
5
Rhabdomyosarcoma
5
Interventions
antineoplaston AS 2-1
3
antineoplaston A10
3
dactolisib
2
Temozolomide
2
Irinotecan
2
Everolimus
2
Bevacizumab
2
surufatinib
1
spartalizumab
1
poly ICLC
1
plerixafor
1
pasireotide
1
fosbretabulin
1
cixutumumab
1
adavosertib
1
Vaccines
1
TH 302
1
Sunitinib
1
Radiotherapy, Image-Guided
1
Radiotherapy
1
Radiation
1
PM 00104
1
Lapatinib
1
Immunologic Techniques
1
Immunoglobulin G
1
Genistein
1
Fentanyl
1
Donepezil
1
Disulfides
1
Decitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neuroectodermal Tumors, Primitive
×
Magnetic Resonance Spectroscopy
×
Clear all
No trials found.